Bank of America
PLRX icon

Bank of America’s Pliant Therapeutics PLRX Stock Holding History

Bank of America’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$444K Sell
352,708
-359,069
-50% -$453K ﹤0.01% 4956
2025
Q4 		$868K Buy
711,777
+3,721
+0.5% +$5.59K ﹤0.01% 4609
2025
Q3 		$1.05M Buy
708,056
+227,526
+47% +$347K ﹤0.01% 5297
2025
Q2 		$557K Sell
480,530
-440,206
-48% -$622K ﹤0.01% 5648
2025
Q1 		$1.24M Buy
920,736
+799,759
+661% +$4.85M ﹤0.01% 5070
2024
Q4 		$1.59M Sell
120,977
-506,719
-81% -$6.92M ﹤0.01% 4638
2024
Q3 		$7.04M Buy
627,696
+23,451
+4% +$293K ﹤0.01% 3413
2024
Q2 		$6.5M Buy
604,245
+106,431
+21% +$1.37M ﹤0.01% 3373
2024
Q1 		$7.42M Buy
497,814
+419,484
+536% +$6.92M ﹤0.01% 3271
2023
Q4 		$1.42M Buy
78,330
+41,145
+111% +$626K ﹤0.01% 4708
2023
Q3 		$645K Sell
37,185
-63,036
-63% -$1.09M ﹤0.01% 5137
2023
Q2 		$1.82M Buy
100,221
+23,699
+31% +$561K ﹤0.01% 4304
2023
Q1 		$2.04M Buy
76,522
+55,221
+259% +$1.57M ﹤0.01% 4335
2022
Q4 		$412K Sell
21,301
-49,056
-70% -$1.03M ﹤0.01% 5515
2022
Q3 		$1.47M Buy
70,357
+56,658
+414% +$1.08M ﹤0.01% 4567
2022
Q2 		$110K Sell
13,699
-4,137
-23% -$26.5K ﹤0.01% 6423
2022
Q1 		$125K Sell
17,836
-8,040
-31% -$82K ﹤0.01% 6741
2021
Q4 		$350K Buy
25,876
+6,468
+33% +$103K ﹤0.01% 6148
2021
Q3 		$327K Buy
19,408
+10,784
+125% +$229K ﹤0.01% 5950
2021
Q2 		$251K Buy
8,624
+1,768
+26% +$55K ﹤0.01% 5939
2021
Q1 		$270K Buy
6,856
+4,280
+166% +$139K ﹤0.01% 5816
2020
Q4 		$59K Buy
2,576
+1,953
+313% +$49K ﹤0.01% 6260
2020
Q3 		$14K Buy
+623
New +$15.6K ﹤0.01% 6365

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Bank of America's PLRX Position: Q1 2026 in Review

Bank of America reduced its Pliant Therapeutics (PLRX) stake by 50% in Q1 2026, selling an estimated $453K and leaving 352,708 shares worth $444K. The position accounts for ﹤0.01% of the portfolio, ranked #4956.

Bank of America first reported a position in PLRX in Q3 2020 and has held it in 23 quarters since. The position peaked at $7.42M in Q1 2024. 91 funds tracked by Wall St. Rank hold PLRX as of Q1 2026.

  • Bank of America held 352,708 shares of Pliant Therapeutics worth $444K as of Q1 2026.
  • Bank of America sold 359,069 Pliant Therapeutics shares in Q1 2026, an estimated $453K.
  • Pliant Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4956 holding.
  • Bank of America first reported a position in Pliant Therapeutics in Q3 2020 and has held it in 23 quarters since.
  • Bank of America's Pliant Therapeutics position peaked at $7.42M in Q1 2024.
  • 91 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.